Jundishapur Journal of Microbiology

Published by: Kowsar

Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran

Abdolhussein Shakurnia 1 , Seyed Mohammad Alavi 2 , Reza Norouzirad 3 , * , Amir Arsalan Sarajian 4 and Ghodratollah Shakerinejad 4
Authors Information
1 Depatment of Immunology, Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Infectious disease, Health Research Institute, Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Biochemistry, Dezful University of Medical Sciences, Dezful, IR Iran
4 Department of Health Research Center, Khuzetan Jahade Daneshgahi, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: December 01, 2013, 6 (10); e7707
  • Published Online: December 1, 2013
  • Article Type: Research Article
  • Received: August 11, 2012
  • Revised: December 23, 2012
  • Accepted: January 16, 2013
  • DOI: 10.5812/jjm.7707

To Cite: Shakurnia A, Alavi S M, Norouzirad R, Sarajian A A, Shakerinejad G. Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran, Jundishapur J Microbiol. 2013 ; 6(10):e7707. doi: 10.5812/jjm.7707.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Christie AS, Gay A. The Measles Initiative: moving toward measles eradication. J Infect Dis. 2011; 204 Suppl 1-7[DOI][PubMed]
  • 2. Hall R, Jolley D. International measles incidence and immunization coverage. J Infect Dis. 2011; 204 Suppl 1-63[DOI][PubMed]
  • 3. Kaninda AV, Legros D, Jataou IM, Malfait P, Maisonneuve M, et al. . Meales vaccine effectiveness in standard early immunization strategies, Niger, 1995. Pediatr Infect Dis J. 1998; 17: 1034-39
  • 4. Gaafar T, Moshni E, Lievano F. The challenge of achieving measles elimination in the Eastern Mediterranean Region by 2010. J Infect Dis. 2003; 187-71
  • 5. Mokhtari Azad T, Mahmoodi M, Hamkar R, et al. . [Epidemiologic feature of measles in Iran, 1995-96]. Hakim Res J. 2000; 1: 19-26
  • 6. Griffine DE. Fields Virology. 2001; : 1401-41
  • 7. Muller CP. Measles elimination: old and new challenges? Vaccine. 2001; 19(17-19): 2258-61[PubMed]
  • 8. Bataweel NA, Al-Robasi AA, Hasoon S, Al-Jabri AA, Sallam TA. Effect of first and second doses of Measles vaccine on immunity to measles among infants in sana’a city, Yaman. J Arab Board Health Special. 2012; 13(1): 10-15
  • 9. Naouri B, Ahmed H, Bekhit R, Teleb N, Mohsni E, Alexander JP, Jr. Progress toward measles elimination in the Eastern Mediterranean Region. J Infect Dis. 2011; 204 Suppl 1-98[DOI][PubMed]
  • 10. Khalil MK, Al-Mazrou YY, AlHowasi MN, Al-Jeffri M. Measles in Saudi Arabia: from control to elimination. Ann Saudi Med. 2005; 25(4): 324-8[PubMed]
  • 11. Zahraei SeyedMohsen, Gouya MohamadM, Azad TalatMokhtari, Soltanshahi Rambod, Sabouri Azam, Naouri Boubker, et al. Successful control and impending elimination of measles in the Islamic Republic of Iran. J Infect Dis. 2011; 204-11
  • 12. Zahraei SM, Sadrizadeh B, Gouya MM. Eradication of poliomyelitis in Iran, a historical perspective. Iran J Public Health. 2009; 38
  • 13. Majdzadeh R, Moradi A, Zeraati H, Sepanlou SG, Zamani G, Zonobi V. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences. East Mediterr Health J. 2008; 14(4): 810-7[PubMed]
  • 14. Morgan OliverWC. Following in the footsteps of smallpox: can we achieve the global eradication of measles? BMC Int Health Hum Rights. 2004; 4(1): 1-5[DOI]
  • 15. Peltola Heikki, Jokinen Sari, Paunio Mikko, Hovi Tapani, Davidkin Irja. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. The Lancet Infect Dis. 2008; 8(12): 796-803
  • 16. Chuang SK, Lau YL, Lim WL, Chow CB, Tsang T, Tse LY. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China. Bull World Health Organ. 2002; 80(7): 585-91[PubMed]
  • 17. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007; 26(12): 1137-41[DOI][PubMed]
  • 18. Salimi V, Mokhtri-azad T, Gooya MM, Hamkar R, Esteghamati AR, Varshochiyani SA, et al. Seroepidemiology of measles in 5-25-year-old age group before measles/rubella mass vaccination campaign in Tabriz (2003). Med J Tabriz Univ. 2006; 28(2): 77-82
  • 19. Jonaidi Jafari N, Ranjbar R, Kakaei M, Ghorbani GhA, Izadi M, Khosravi A, et al. [The Evaluation of Anti Measles IgG Antibody Level Five Years After Mass Vaccination of Measles- Rubella Among The Medical Students of Baqiyatallah University of Medical Sciences]. Sci J Ilam U Med Sci. 2010; 18(1): 34-9
  • 20. Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran. Int J Infect Dis. 2008; 12(1): 43-6[DOI][PubMed]
  • 21. Savad Koohi R, Hajian K, Noori NA, Attarieh M. [Measurement of Measles antibody in 157 children aged 4-6 years referred to Amirkola Children Hospital, 2003-2004]. J Babol Univ Med Sci. 2006; 8(3): 55-9
  • 22. Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, Ziaei T. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol. 2012; 5(4): 578-81[DOI]
  • 23. Yekta Z, Porali R, Taravati MR, Salary Sh, Khalily F, Shahabi S. Measles IgG sero-prevalence and its attributable factors in 5–25-year-old cases prior mass vaccination campaign in Urmia, northeastern Iran. Iran Red Crescent Med J. 2007; 9(1): 28-35
  • 24. Gozalan A, Korukluoglu G, Kurtoglu D, Miyamura K, Yilmaz N, Morita M, et al. Measles seroepidemiology in 3 cities in Turkey. Saudi Med J. 2005; 26(12): 1971-7[PubMed]
  • 25. Glass K, Grenfell BT. Waning immunity and subclinical measles infections in England. Vaccine. 2004; 22(29-30): 4110-6[DOI][PubMed]
  • 26. Gidding HF, Gilbert GL. Measles immunity in young Australian adults. Commun Dis Intell Q Rep. 2001; 25(3): 133-6[PubMed]
  • 27. Emami Naeini A, Ghazavi N, Emami Naeini S. Measurement of serum antibody Titer against Measles in a group of adults receiving Measles-Rubella mass vaccination. J Isfahan Med Sch. 2011; 28(114): 854-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments